Veterinary Medicines

Bovilis BVD Suspension for injection for cattle

Authorised
  • Bovine viral diarrhoea virus 1, strain C-86, Inactivated
Download as PDF

Product identification

Medicine name:
Bovilis BVD Suspension for injection for cattle
Bovilis BVD Suspension injectable
Active substance:
  • Bovine viral diarrhoea virus 1, strain C-86, Inactivated
Target species:
  • Cattle
  • Cattle (for meat production)
  • Cattle (dairy cow)
  • Cattle (calf)
  • Cattle (heifer)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Bovine viral diarrhoea virus 1, strain C-86, Inactivated
    50.00
    enzyme-linked immunosorbent assay unit
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Cattle (for meat production)
      • Meat and offal
        0
        day
    • Cattle (dairy cow)
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Cattle (heifer)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:
  • (ID7) 100 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 100 millilitre(s)
  • (ID6) 50 millilitre(s): Box (Cardboard) with 1 Bottle (PolyEthylene TerePhthalate) with 50 millilitre(s)
  • (ID1) 10 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 10 millilitre(s)
  • (ID20) 2 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 2 millilitre(s)
  • (ID30) 2 millilitre(s): Box (Cardboard) with 1 Bottle (PolyEthylene TerePhthalate) with 2 millilitre(s)
  • (ID3) 20 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 20 millilitre(s)
  • (ID9) 250 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 250 millilitre(s)
  • (ID4) 20 millilitre(s): Box (Cardboard) with 1 Bottle (PolyEthylene TerePhthalate) with 20 millilitre(s)
  • (ID2) 10 millilitre(s): Box (Cardboard) with 1 Bottle (PolyEthylene TerePhthalate) with 10 millilitre(s)
  • (ID5) 50 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 50 millilitre(s)
  • (ID8) 100 millilitre(s): Box (Cardboard) with 1 Bottle (PolyEthylene TerePhthalate) with 100 millilitre(s)
  • (ID10) 250 millilitre(s): Box (Cardboard) with 1 Bottle (PolyEthylene TerePhthalate) with 250 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
  • V/817/99/08/0644
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0211/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • France
  • Greece
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download
French (PDF)
Published on: 15/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."